30.93
price down icon2.95%   -0.94
pre-market  Pre-mercato:  31.37   0.44   +1.42%
loading
Precedente Chiudi:
$31.87
Aprire:
$31.52
Volume 24 ore:
10.03M
Relative Volume:
0.97
Capitalizzazione di mercato:
$11.90B
Reddito:
$5.06B
Utile/perdita netta:
$-2.22B
Rapporto P/E:
-5.3144
EPS:
-5.82
Flusso di cassa netto:
$-3.96B
1 W Prestazione:
-9.48%
1M Prestazione:
-26.79%
6M Prestazione:
-63.58%
1 anno Prestazione:
-64.62%
Intervallo 1D:
Value
$30.70
$32.42
Intervallo di 1 settimana:
Value
$30.70
$35.57
Portata 52W:
Value
$30.70
$170.47

Moderna Inc Stock (MRNA) Company Profile

Name
Nome
Moderna Inc
Name
Telefono
(617) 714-6500
Name
Indirizzo
325 BINNEY STREET, CAMBRIDGE
Name
Dipendente
5,600
Name
Cinguettio
@moderna_tx
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
MRNA's Discussions on Twitter

Confronta MRNA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MRNA
Moderna Inc
30.93 11.90B 5.06B -2.22B -3.96B -5.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
455.22 117.23B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
665.46 72.75B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
636.02 38.65B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.99 34.69B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
114.50 27.45B 3.30B -501.07M 1.03B -2.1146

Moderna Inc Stock (MRNA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-01-29 Downgrade Goldman Buy → Neutral
2024-12-18 Downgrade Argus Buy → Hold
2024-12-10 Ripresa BofA Securities Underperform
2024-11-19 Iniziato Berenberg Hold
2024-11-18 Aggiornamento HSBC Securities Hold → Buy
2024-11-15 Iniziato Wolfe Research Underperform
2024-10-17 Iniziato Bernstein Mkt Perform
2024-09-13 Downgrade JP Morgan Neutral → Underweight
2024-09-13 Downgrade Jefferies Buy → Hold
2024-09-13 Downgrade Oppenheimer Outperform → Perform
2024-08-28 Aggiornamento HSBC Securities Reduce → Hold
2024-08-07 Aggiornamento Deutsche Bank Sell → Hold
2024-08-05 Downgrade RBC Capital Mkts Outperform → Sector Perform
2024-02-26 Downgrade HSBC Securities Hold → Reduce
2024-01-02 Aggiornamento Oppenheimer Perform → Outperform
2023-11-29 Iniziato Canaccord Genuity Hold
2023-11-03 Aggiornamento HSBC Securities Reduce → Hold
2023-11-02 Downgrade Deutsche Bank Hold → Sell
2023-08-04 Downgrade TD Cowen Outperform → Market Perform
2023-08-03 Downgrade Deutsche Bank Buy → Hold
2023-07-24 Iniziato William Blair Mkt Perform
2023-07-14 Iniziato HSBC Securities Reduce
2023-06-26 Aggiornamento UBS Neutral → Buy
2023-04-26 Iniziato Guggenheim Neutral
2023-03-13 Aggiornamento TD Cowen Market Perform → Outperform
2023-03-02 Iniziato RBC Capital Mkts Outperform
2023-02-24 Downgrade SVB Securities Market Perform → Underperform
2022-12-19 Aggiornamento Jefferies Hold → Buy
2022-12-14 Downgrade Chardan Capital Markets Buy → Neutral
2022-10-21 Aggiornamento SVB Leerink Underperform → Mkt Perform
2022-09-08 Aggiornamento Deutsche Bank Hold → Buy
2022-02-01 Aggiornamento Redburn Sell → Neutral
2022-01-26 Aggiornamento Deutsche Bank Sell → Hold
2022-01-21 Aggiornamento BofA Securities Underperform → Neutral
2022-01-21 Iniziato UBS Neutral
2021-12-07 Iniziato Cowen Market Perform
2021-11-09 Iniziato Wolfe Research Outperform
2021-10-22 Iniziato Deutsche Bank Sell
2021-10-15 Aggiornamento Piper Sandler Neutral → Overweight
2021-08-06 Downgrade Oppenheimer Outperform → Perform
2021-08-06 Downgrade Piper Sandler Overweight → Neutral
2021-07-15 Reiterato Jefferies Hold
2021-02-01 Downgrade BofA Securities Neutral → Underperform
2020-12-16 Downgrade Jefferies Buy → Hold
2020-12-16 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-12-09 Downgrade Needham Buy → Hold
2020-11-23 Iniziato Wells Fargo Equal Weight
2020-11-17 Downgrade BMO Capital Markets Outperform → Market Perform
2020-09-08 Downgrade SVB Leerink Mkt Perform → Underperform
2020-07-23 Iniziato SVB Leerink Mkt Perform
2020-07-20 Downgrade JP Morgan Overweight → Neutral
2020-07-13 Iniziato Jefferies Buy
2020-06-30 Iniziato Argus Buy
2020-06-08 Iniziato Barclays Overweight
2020-04-30 Iniziato BMO Capital Markets Outperform
2020-03-05 Downgrade BofA/Merrill Buy → Neutral
2019-12-03 Ripresa BofA/Merrill Buy
2019-10-25 Iniziato ROTH Capital Buy
2019-04-05 Iniziato Chardan Capital Markets Buy
Mostra tutto

Moderna Inc Borsa (MRNA) Ultime notizie

pulisher
07:14 AM

Could Moderna’s (MRNA) 65% Stock Plunge Entice a Takeover? - Markets Insider

07:14 AM
pulisher
05:48 AM

Analysts recommendations: Gsk, Halma, Bellway, On Holding, Moderna… - Marketscreener.com

05:48 AM
pulisher
05:41 AM

Analysts recommendations: Lyft, Coty, Upstart, On Holding, Moderna... - Marketscreener.com

05:41 AM
pulisher
05:10 AM

Moderna (MRNA) Projected to Post Quarterly Earnings on Friday - MarketBeat

05:10 AM
pulisher
04:21 AM

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat

04:21 AM
pulisher
04:21 AM

Bank of America Issues Pessimistic Forecast for Moderna (NASDAQ:MRNA) Stock Price - MarketBeat

04:21 AM
pulisher
Feb 11, 2025

abrdn plc Purchases 69,360 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Feb 11, 2025
pulisher
Feb 11, 2025

What the Options Market Tells Us About Moderna - Benzinga

Feb 11, 2025
pulisher
Feb 11, 2025

Moderna stock target cut at BofA as key challenges persist By Investing.com - Investing.com Nigeria

Feb 11, 2025
pulisher
Feb 11, 2025

BofA Securities Cuts Moderna Price Target to $34 From $41, Maintains Underperform Rating - Marketscreener.com

Feb 11, 2025
pulisher
Feb 11, 2025

Bank of America Cuts Moderna (NASDAQ:MRNA) Price Target to $34.00 - MarketBeat

Feb 11, 2025
pulisher
Feb 11, 2025

Moderna Stock: A Deep Dive Into Analyst Perspectives (11 Ratings) - Benzinga

Feb 11, 2025
pulisher
Feb 11, 2025

Moderna’s Underperform Rating: Challenges in Revenue Diversification and Forecasting Amid Pandemic Volatility - TipRanks

Feb 11, 2025
pulisher
Feb 11, 2025

Why Moderna Inc. (MRNA) Crashed Last Week - MSN

Feb 11, 2025
pulisher
Feb 11, 2025

Mirae Asset Global Investments Co. Ltd. Trims Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Feb 11, 2025
pulisher
Feb 11, 2025

US Not Liable In Moderna Covid-19 Vaccine Patent Case: Second Judge - BW Healthcare World

Feb 11, 2025
pulisher
Feb 10, 2025

Taiwan Approves Omicron-targeted Moderna Covid Vaccine - BW Healthcare World

Feb 10, 2025
pulisher
Feb 10, 2025

Moderna (MRNA) Projected to Post Earnings on Friday - MarketBeat

Feb 10, 2025
pulisher
Feb 10, 2025

Quattro Financial Advisors LLC Raises Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Feb 10, 2025
pulisher
Feb 10, 2025

Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch - Benzinga

Feb 10, 2025
pulisher
Feb 09, 2025

Stock Showdown: Why Robinhood is a Buy and Moderna is Tumbling! - Jomfruland.net

Feb 09, 2025
pulisher
Feb 09, 2025

1 Stock to Buy, 1 Stock to Sell This Week: Robinhood, Moderna - Yahoo Finance

Feb 09, 2025
pulisher
Feb 09, 2025

Estee Lauder, Moderna And PayPal Are Among Top 10 Large Cap Losers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio? - Benzinga

Feb 09, 2025
pulisher
Feb 09, 2025

Moderna (NASDAQ:MRNA) Shares Down 4.7%What's Next? - MarketBeat

Feb 09, 2025
pulisher
Feb 08, 2025

Why Moderna, Inc. (MRNA) Is Among the Best Healthcare Stocks To Buy According to Analysts - Insider Monkey

Feb 08, 2025
pulisher
Feb 08, 2025

Spire Wealth Management Increases Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Feb 08, 2025
pulisher
Feb 08, 2025

Robeco Institutional Asset Management B.V. Has $1.33 Million Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Feb 08, 2025
pulisher
Feb 07, 2025

No, Moderna Did Not Create Its COVID Vaccine Two Years Before the Pandemic - Yahoo

Feb 07, 2025
pulisher
Feb 07, 2025

Moderna Inc Testing Potential Monkeypox Vaccines - BW Healthcare World

Feb 07, 2025
pulisher
Feb 07, 2025

Do Wall Street Analysts Like Moderna Stock? - MSN

Feb 07, 2025
pulisher
Feb 07, 2025

Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Yahoo Finance

Feb 07, 2025
pulisher
Feb 07, 2025

Moderna Poised to Report Q4 Earnings: Is a Beat in the Cards? - Yahoo Finance

Feb 07, 2025
pulisher
Feb 06, 2025

Moderna (NASDAQ:MRNA) Trading Down 4.7%Here's Why - MarketBeat

Feb 06, 2025
pulisher
Feb 06, 2025

Pacer Advisors Inc. Sells 20,901 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Feb 06, 2025
pulisher
Feb 06, 2025

Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now? - AOL

Feb 06, 2025
pulisher
Feb 06, 2025

Is Moderna Stock A Sell With Robert F. Kennedy Eyeing The Lead Role At HHS? - Yahoo

Feb 06, 2025
pulisher
Feb 06, 2025

KBC Group NV Sells 38,943 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Feb 06, 2025
pulisher
Feb 06, 2025

Sell Rating for Moderna Amid Regulatory Concerns and Stock Volatility - TipRanks

Feb 06, 2025
pulisher
Feb 05, 2025

Swedbank AB Boosts Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Feb 05, 2025
pulisher
Feb 05, 2025

Everett Harris & Co. CA Invests $275,000 in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Feb 05, 2025
pulisher
Feb 05, 2025

Why Moderna, Inc. (MRNA) Went Down on Tuesday - MSN

Feb 05, 2025
pulisher
Feb 05, 2025

MRNA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Moderna, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 05, 2025
pulisher
Feb 04, 2025

Why Moderna Inc. (MRNA) Crashed on Monday - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Moderna call volume above normal and directionally bullish - TipRanks

Feb 04, 2025
pulisher
Feb 04, 2025

Global mRNA Vaccines and Therapeutics Market is expected - openPR

Feb 04, 2025
pulisher
Feb 04, 2025

Moderna and BioNTech shares fall after Senate committee vote RFK Jr. - Investing.com Canada

Feb 04, 2025
pulisher
Feb 04, 2025

This Is What Whales Are Betting On Moderna - Benzinga

Feb 04, 2025

Moderna Inc Azioni (MRNA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$79.89
price up icon 2.27%
$32.25
price up icon 1.67%
$4.47
price down icon 5.10%
$353.31
price up icon 2.22%
biotechnology ONC
$221.22
price up icon 0.71%
$114.50
price down icon 0.67%
Capitalizzazione:     |  Volume (24 ore):